Evidence map›Paper›PMID 38129816›Full record

ArticleBMC public health2023

Challenges in conducting population-based seroepidemiology survey of COVID-19 in Lagos State, Nigeria.

Adewale Kayode Ojogbede, Tajudeen Akanji Bamidele, Oluwagbemiga Aina, Toyosi Raheem, Azuka Okwuraiwe, Olufemi Amoo, Kazeem Adewale Osuolale, David Oladele, Abideen Salako, Fehintola Ige and 10 more

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Adewale Kayode OjogbedePublic Health and Epidemiology Department, Nigerian Institute of Medical Research, Lagos, Nigeria. waleojogbede@gmail.com.
Tajudeen Akanji BamideleMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Oluwagbemiga AinaBiochemistry and Nutrition Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Toyosi RaheemMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Azuka OkwuraiweCenter for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Olufemi AmooCenter for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Kazeem Adewale OsuolaleMonitoring and Evaluation Unit, Nigerian Institute of Medical Research, Lagos, Nigeria.
David OladeleClinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Abideen SalakoClinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Fehintola IgeCenter for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Adesola Zaidat MusaMonitoring and Evaluation Unit, Nigerian Institute of Medical Research, Lagos, Nigeria.
Ifeoma IdigbeClinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Fatimah AnwojuCenter for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Basit BaruwaLagos Bureau of Statistics (LBS), Ministry of Economic Planning and Budget (MEPB), Lagos, Lagos State, Nigeria.
Hussein Abdur-RazzakDepartment of Research and Statistics, Lagos State Ministry of Health, Lagos, Nigeria.
Bisola AdebayoDepartment of Community Health & Primary Health Care, Lagos State University College of Medicine, Lagos, Nigeria.
Kikelomo WrightDepartment of Community Health & Primary Health Care, Lagos State University College of Medicine, Lagos, Nigeria.
Aigbe OhihoinClinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Oliver EzechiClinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Rosemary AuduCenter for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.

Funding

University College London WT 5049153
6 · The paper itself

Abstract

Population-based study is known to be a very essential type of study during and after a pandemic or epidemic, as it provides crucial information on the incidence, prevalence, and risk factors of the disease in question. There has been limited information about the challenges faced in conducting such surveys in Nigeria. In this paper, we will share our experience, and describe the challenges faced in conducting a population-based seroepidemiological study of COVID-19 in Lagos, Nigeria. Some challenges were peculiar to specific Local Government Areas (LGAs) while others were general. The challenges include general misconceptions of community members about health research, difficulties in mapping houses, planning for data collection, standardizing data collection, working in hard-to-reach communities when resources were limited as well as difficulty in collection of blood and naso-oropharyngeal swabs. Ways of overcoming these problems, lessons learnt, and recommendations are hereby discussed.

Indexed as

COVID-19HumansNigeriaPandemicsSeroepidemiologic StudiesSurveys and QuestionnairesCOVID-19Lagos StateNaso-oropharyngeal swabsSeroepidemiological study

Identifiers

PMID38129816
PMCPMC10740330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.